Niox Group is a specialty biopharmaceutical company focused on the development and commercialisation of a range of immunotherapy product candidates for the treatment of allergy.
| Non-Executive Director: |
Nicholas Mills |
| Executive Chairman: |
Ian Johnson |
| Senior Independent Director: |
Garry Watts |
| Chief Finance Officer: |
Michael R D Roller |
| Independent Non-Executive Director: |
Sharon Curran, Jo Le Couilliard |
| Chief Operating Officer: |
Jonathan Emms |
| Address: |
Hayakawa Building, Edmund Halley Road, Oxford Science Park, Oxford, United Kingdom |
| Phone: |
+44 (0)1865 405560 |
| Fax: |
+44 (0)7092 987560 |
| Website: |
http://www.niox.com/ |
| Email: |
|